Identity
- Trade Name
- LIAISON XL MUREX Control Anti-HBe FDA UDI
- Generic Name
- Hepatitis B virus e-antigen total antibody IVD, control FDA UDI
- Model / Reference
- 318161 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 08056771103435 FDA UDI
- GMDN Term
- Hepatitis B virus e-antigen total antibody IVD, control FDA UDI
Classification
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Hepatitis B virus e-antigen total antibody IVD, control
LIAISON XL MUREX Control Anti-HBe by Diasorin Inc. — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Hepatitis B virus e-antigen total antibody IVD, control.
- VIROTROL — Bio-Rad Laboratories · Class I
- ADVIA Centaur aHBe2 QC KIT — Siemens Healthcare Diagnostics · Class II
- Atellica IM aHBe2 QC — Siemens Healthcare Diagnostics · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | N/A | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Diasorin Inc.
Sources (1)
- FDA UDI fdd8a1da-e654-4456-a822-519e162a2c11 32 fields · synced Jun 1, 2026